STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 15 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,310,000 | -16.1% | 1,100,000 | +93.7% | 0.12% | -31.7% |
| Q3 2018 | $2,754,000 | -19.2% | 567,895 | 0.0% | 0.18% | -40.0% |
| Q2 2018 | $3,407,000 | -32.2% | 567,895 | 0.0% | 0.30% | -37.2% |
| Q1 2018 | $5,026,000 | +22.1% | 567,895 | 0.0% | 0.49% | +20.6% |
| Q4 2017 | $4,117,000 | +5.1% | 567,895 | 0.0% | 0.40% | -51.2% |
| Q3 2017 | $3,918,000 | -3.5% | 567,895 | -0.0% | 0.82% | -17.7% |
| Q2 2017 | $4,060,000 | +43.7% | 567,896 | -4.6% | 1.00% | +18.8% |
| Q1 2017 | $2,826,000 | +94.1% | 595,029 | -1.9% | 0.84% | -27.3% |
| Q4 2016 | $1,456,000 | -60.5% | 606,607 | -14.0% | 1.16% | -19.3% |
| Q3 2016 | $3,683,000 | +31.2% | 705,481 | +0.0% | 1.44% | +19.3% |
| Q2 2016 | $2,808,000 | +4.8% | 705,480 | +81.4% | 1.20% | +200.5% |
| Q4 2015 | $2,679,000 | – | 388,945 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $15,803,000 | 17.82% |
| Prosight Management, LP | 2,515,072 | $6,011,000 | 3.33% |
| 22NW, LP | 804,410 | $1,923,000 | 2.54% |
| Broadfin Capital, LLC | 2,578,003 | $6,161,000 | 1.14% |
| NEA Management Company, LLC | 4,141,308 | $9,898,000 | 0.82% |
| Opaleye Management Inc. | 490,000 | $1,171,000 | 0.42% |
| PA Capital LLC | 152,977 | $366,000 | 0.36% |
| 683 Capital Management, LLC | 923,700 | $2,208,000 | 0.25% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 414,982 | $992,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,475,000 | $3,525,000 | 0.10% |